US Bancorp DE lifted its holdings in SunOpta Inc. (NASDAQ:STKL – Free Report) (TSE:SOY) by 139.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,197 shares of the company’s stock after buying an additional 4,772 shares during the quarter. US Bancorp DE’s holdings in SunOpta were worth $52,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. First Bank & Trust raised its stake in SunOpta by 7.9% in the 3rd quarter. First Bank & Trust now owns 25,409 shares of the company’s stock valued at $162,000 after purchasing an additional 1,856 shares during the last quarter. Mackenzie Financial Corp grew its holdings in SunOpta by 0.9% during the 2nd quarter. Mackenzie Financial Corp now owns 254,678 shares of the company’s stock valued at $1,370,000 after purchasing an additional 2,155 shares in the last quarter. Creative Planning boosted its position in SunOpta by 9.3% in the 3rd quarter. Creative Planning now owns 30,716 shares of the company’s stock valued at $196,000 after buying an additional 2,617 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of SunOpta by 13.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 26,913 shares of the company’s stock valued at $185,000 after acquiring an additional 3,171 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its position in shares of SunOpta by 10.5% during the second quarter. The Manufacturers Life Insurance Company now owns 36,958 shares of the company’s stock worth $200,000 after acquiring an additional 3,521 shares during the last quarter. Institutional investors and hedge funds own 85.39% of the company’s stock.
SunOpta Stock Performance
STKL opened at $7.29 on Monday. SunOpta Inc. has a fifty-two week low of $4.37 and a fifty-two week high of $7.75. The firm has a market cap of $870.78 million, a PE ratio of -40.50 and a beta of 1.83. The company has a quick ratio of 0.53, a current ratio of 1.20 and a debt-to-equity ratio of 1.61. The business has a fifty day simple moving average of $6.52 and a 200-day simple moving average of $5.92.
Wall Street Analysts Forecast Growth
STKL has been the subject of a number of recent analyst reports. StockNews.com raised shares of SunOpta from a “sell” rating to a “hold” rating in a research report on Saturday, November 9th. DA Davidson restated a “buy” rating and issued a $9.00 target price on shares of SunOpta in a research report on Thursday, October 10th. Finally, Stephens raised their target price on shares of SunOpta from $9.00 to $10.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $9.50.
View Our Latest Analysis on STKL
Insider Activity at SunOpta
In other SunOpta news, insider Robert Duchscher sold 50,000 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $7.33, for a total value of $366,500.00. Following the transaction, the insider now owns 42,971 shares in the company, valued at $314,977.43. The trade was a 53.78 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 6.48% of the stock is currently owned by insiders.
SunOpta Profile
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Featured Stories
- Five stocks we like better than SunOpta
- How to Read Stock Charts for Beginners
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Transportation Stocks Investing
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Want to Profit on the Downtrend? Downtrends, Explained.
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for SunOpta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SunOpta and related companies with MarketBeat.com's FREE daily email newsletter.